Cancer Immunotherapy Trials Network (CITN), FHCRC

United States of America (USA)

1 December 2019 - 30 November 2020

No articles found. Cancer Immunotherapy Trials Network (CITN), FHCRC did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

Fred Hutchinson Cancer Research Center (FHCRC)

↳ Cancer Immunotherapy Trials Network (CITN), FHCRC

Basic Sciences Division, FHCRC

Bioinformatics Resource, FHCRC

Cape Town HVTN Immunology Laboratory (CHIL) / Hutchinson Centre Research Institute of South Africa

Cell and Gene Therapy Program, FHCRC

Clinical Research Division, FHCRC

Program in Immunology, FHCRC

Comparative Medicine, FHCRC

Comparative Pathology, FHCRC

Genomics Resource, FHCRC

HIV Vaccine Trials Network (HVTN), FHCRC

Human Biology Division, FHCRC

Immunotherapy Integrated Research Center (IIRC), FHCRC

Proteomics Facility, FHCRC

Public Health Sciences Division (PHS), FHCRC

Cancer Prevention Program, FHCRC

Epidemiology Program, FHCRC

Herbold Computational Biology Program, FHCRC

Program in Biostatistics and Biomathematics, FHCRC

Tobacco and Health Behavior Science Research Group, FHCRC

Translational Research Program, FHCRC

Statistical Center for HIV/AIDS Research and Prevention (SCHARP)

Vaccine and Infectious Disease Division (VIDD), FHCRC

Women's Health Initiative Clinical Coordinating Center, FHCRC

Return to institution outputs

Latest supplement

Nature Index 2020 Artificial Intelligence

Artificial intelligence is one of the most rapidly advancing and controversial topics in scientific research. As investments and revenues soar year-on-year and nations vie for leadership in the field, AI research output continues its steep, upward trajectory. But there are significant ethical and technical challenges to overcome.

Access free

Research highlights of partners

Research highlights

Sign up for the free weekly Nature Index newsletter
Sign up

Useful links